Gene · 2237
Papers3,948
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,948
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptional CDK Inhibitors as Potential Treatment Option for Testicular Germ Cell Tumors. | Cancers (Basel) | 2022 | 35406461 | PubTator, text mining | PubMed |
| Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma. | Front Surg | 2022 | 35392063 | PubTator, text mining | PubMed |
| Expression of DNA-damage response and repair genes after exposure to DNA-damaging agents in isogenic head and neck cells with altered radiosensitivity. | Radiol Oncol | 2022 | 35390246 | PubTator, text mining | PubMed |
| Fast Detection of Snakes and Emotional Faces in the Macaque Amygdala. | Front Behav Neurosci | 2022 | 35386724 | PubTator, text mining | PubMed |
| Observation of the cervical microbiome in the progression of cervical intraepithelial neoplasia. | BMC Cancer | 2022 | 35379200 | PubTator, text mining | PubMed |
| PA1 cells containing a truncated DNA polymerase β protein are more sensitive to gamma radiation. | Radiat Oncol J | 2022 | 35368202 | PubTator, text mining | PubMed |
| Chromatin-remodeling factor CHR721 with non-canonical PIP-box interacts with OsPCNA in Rice. | BMC Plant Biol | 2022 | 35365089 | PubTator, text mining | PubMed |
| Correlations Between the Expression of Stromal Cell Activation Related Biomarkers, L-NGFR, Phospho-ERK1-2 and CXCL12, and Primary Myelofibrosis Progression. | Pathol Oncol Res | 2022 | 35356507 | PubTator, text mining | PubMed |
| Downregulation of MEIS1 mediated by ELFN1-AS1/EZH2/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer. | Signal Transduct Target Ther | 2022 | 35351858 | PubTator, text mining | PubMed |
| Cadherin-16 inhibits thyroid carcinoma cell proliferation and invasion. | Oncol Lett | 2022 | 35350592 | PubTator, text mining | PubMed |
| Cytotoxicity, crosslinking and biological activity of three mitomycins. | Bioorg Chem | 2022 | 35349830 | PubTator, text mining | PubMed |
| A Combined Treatment with Berberine and Andrographis Exhibits Enhanced Anti-Cancer Activity through Suppression of DNA Replication in Colorectal Cancer. | Pharmaceuticals (Basel) | 2022 | 35337060 | PubTator, text mining | PubMed |
| PARP inhibition impedes the maturation of nascent DNA strands during DNA replication. | Nat Struct Mol Biol | 2022 | 35332322 | PubTator, text mining | PubMed |
| CDK1 and HSP90AA1 Appear as the Novel Regulatory Genes in Non-Small Cell Lung Cancer: A Bioinformatics Approach. | J Pers Med | 2022 | 35330393 | PubTator, text mining | PubMed |
| Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy. | Int J Mol Sci | 2022 | 35328658 | PubTator, text mining | PubMed |
| Gene Expression over Time during Cell Transformation Due to Non-Genotoxic Carcinogen Treatment of Bhas 42 Cells. | Int J Mol Sci | 2022 | 35328637 | PubTator, text mining | PubMed |
| Role of Base Excision Repair in Innate Immune Cells and Its Relevance for Cancer Therapy. | Biomedicines | 2022 | 35327359 | PubTator, text mining | PubMed |
| Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases. | Curr Oncol | 2022 | 35323322 | PubTator, text mining | PubMed |
| AOP report: Development of an adverse outcome pathway for oxidative DNA damage leading to mutations and chromosomal aberrations. | Environ Mol Mutagen | 2022 | 35315142 | PubTator, text mining | PubMed |
| Identification of the Signature Genes and Network of Reactive Oxygen Species Related Genes and DNA Repair Genes in Lung Adenocarcinoma. | Front Med (Lausanne) | 2022 | 35308531 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2237/papers?page=45